The immunobiology of the receptor of advanced glycation end-products: Trends and challenges

被引:55
作者
Gonzalez, Ileana [1 ]
Romero, Jacqueline [1 ]
Rodriguez, Boris L. [2 ]
Perez-Castro, Ramon [1 ]
Rojas, Armando [1 ]
机构
[1] Catholic Univ Maule, Fac Med, Biomed Res Labs, Talca, Chile
[2] Natl Ctr Sci Res, Dept Microbiol & Immunol, Havana 6880, Cuba
关键词
Alarmins; DAMPs; Innate immunity; Inflammation; RAGE; PAMPs; Toll receptors; RAGE GENE PROMOTER; CORONARY-ARTERY-DISEASE; CLASS-III REGION; S100; PROTEINS; ENDPRODUCTS RAGE; THE-374A ALLELE; VASCULAR COMPLICATIONS; DIABETIC-NEPHROPATHY; PATTERN-RECOGNITION; SIGNALING PATHWAYS;
D O I
10.1016/j.imbio.2012.09.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Pattern-recognition receptors have been highly conserved in evolution. They recognize danger signals including both pathogen- and damage-associated molecular patterns, also known as alarmins. Several signaling pathways leading to an inflammatory reaction as part of an effective defensive response, are thus triggered. RAGE, a receptor initially considered for advanced glycation end-products, is also known to be activated by several danger signals, thus functioning as a pattern-recognition receptor. As a new member of this family, attempts to unraveling its functioning show that RAGE activation not only results in innate immune response but also contributes to promote and shape the acquired immune reaction. As reported for other members of the family, RAGE presents many polymorphic variants and additional studies are needed to elucidate its significance in immune response and disease susceptibility. Here we describe recent advances unraveling RAGE functions, as well as its significance and challenges in immunobiology. (C) 2012 Elsevier GmbH. All rights reserved.
引用
收藏
页码:790 / 797
页数:8
相关论文
共 119 条
[1]
Abdel-Azeez Hala A, 2009, Egypt J Immunol, V16, P95
[2]
The role of hyperglycemia in mechanisms of exacerbated inflammatory responses within the oral cavity [J].
Amir, Jamie ;
Waite, Matthew ;
Tobler, Jeffrey ;
Catalfamo, Dana L. ;
Koutouzis, Theofilos ;
Katz, Joseph ;
Wallet, Shannon M. .
CELLULAR IMMUNOLOGY, 2011, 272 (01) :45-52
[3]
HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection [J].
Andersson, Ulf ;
Tracey, Kevin J. .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29, 2011, 29 :139-162
[4]
Expression of CD64, CD206, and RAGE in adherent cells of diabetic patients infected with Mycobacterium tuberculosis [J].
Arce-Mendoza, Alma ;
Ita, Julieta Rodriguez-de ;
Salinas-Carmona, Mario C. ;
Rosas-Taraco, Adrian G. .
ARCHIVES OF MEDICAL RESEARCH, 2008, 39 (03) :306-311
[5]
Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy [J].
Balasubbu, Suganthalakshmi ;
Sundaresan, Periasamy ;
Rajendran, Anand ;
Ramasamy, Kim ;
Govindarajan, Gowthaman ;
Perumalsamy, Namperumalsamy ;
Hejtmancik, J. Fielding .
BMC MEDICAL GENETICS, 2010, 11
[6]
Cytoplasmic DNA innate immune pathways [J].
Barber, Glen N. .
IMMUNOLOGICAL REVIEWS, 2011, 243 :99-108
[7]
CHIMERIC TUMOR-NECROSIS-FACTOR RECEPTORS WITH CONSTITUTIVE SIGNALING ACTIVITY [J].
BAZZONI, F ;
ALEJOS, E ;
BEUTLER, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5376-5380
[8]
Understanding RAGE, the receptor for advanced glycation end products [J].
Bierhaus, A ;
Humpert, PM ;
Morcos, M ;
Wendt, T ;
Chavakis, T ;
Arnold, B ;
Stern, DM ;
Nawroth, PP .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (11) :876-886
[9]
Association of biochemical parameters and RAGE gene polymorphisms in healthy infants and their mothers [J].
Boor, P. ;
Celec, P. ;
Klenovicsova, K. ;
Vlkova, B. ;
Szemes, T. ;
Minarik, G. ;
Turna, J. ;
Sebekova, K. .
CLINICA CHIMICA ACTA, 2010, 411 (15-16) :1034-1040
[10]
MOLECULAR STUDY OF RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCT GENE PROMOTER AND IDENTIFICATION OF SPECIFIC HLA HAPLOTYPES POSSIBLY INVOLVED IN CHRONIC FATIGUE SYNDROME [J].
Carlo-Stella, N. ;
Bozzini, S. ;
De Silvestri, A. ;
Sbarsi, I. ;
Pizzochero, C. ;
Lorusso, L. ;
Martinetti, M. ;
Cuccia, M. .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (03) :745-754